The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Predictive associations between serum dehydroepiandrosterone sulfate (DHEAS) and race among patients (pts) treated with apalutamide (apa), abiraterone acetate (AA) plus prednisone (P) in the PANTHER study.
 
Daniel George
Leadership - Capio BioSciences
Stock and Other Ownership Interests - Pfizer
Honoraria - American Association for Cancer Research; Astellas Pharma; AstraZeneca; Aveo; Axess Oncology; Bayer; Eisai; EMD Serono; Exelixis; IDEOlogy Health; Janssen Oncology; Merck; Millennium Medical Publishing; Myovant Sciences; Novartis; OncLive; Pfizer; UroToday
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Exelixis; Janssen; Merck Sharp & Dohme; Michael J. Hennessy Associates; Myovant Sciences; Novartis; Pfizer; Physicans' Education Resource
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Corvus Pharmaceuticals (Inst); Exelixis (Inst); Janssen Oncology (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst)
Expert Testimony - Exelixis
Travel, Accommodations, Expenses - Bayer; Exelixis; Merck; Novartis; Pfizer
 
Lauren Howard
Consulting or Advisory Role - Tempus
 
Susan Halabi
Employment - ASCO
Consulting or Advisory Role - BeiGene; Bristol-Myers Squibb; CG Oncology; J&J; Sanofi
 
Terry Hyslop
Research Funding - Pfizer
 
Bonnie LaCroix
No Relationships to Disclose
 
Alvin Matsumoto
No Relationships to Disclose
 
Julia Hurrelbrink
No Relationships to Disclose
 
Julie Kephart
No Relationships to Disclose
 
Julia Rasmussen
Research Funding - Flatiron Health
 
Marco Reyes-Martinez
No Relationships to Disclose
 
Kellie Shobe
No Relationships to Disclose
 
Steven Gray
No Relationships to Disclose
 
Monika Anand
No Relationships to Disclose
 
Steven Patierno
Leadership - Curaleaf; Theralogix
Stock and Other Ownership Interests - Curaleaf
Consulting or Advisory Role - Curaleaf; Theralogix
Research Funding - AstraZeneca
Patents, Royalties, Other Intellectual Property - pending
 
Andrew Armstrong
Consulting or Advisory Role - Astellas Scientific and Medical Affairs Inc; AstraZeneca; Bayer; Bristol-Myers Squibb; Cytogen; Exelixis; GoodRx; Janssen; Merck; Myovant Sciences; Novartis; Pfizer
Research Funding - Amgen (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Janssen Oncology (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Syntrix Biosystems (Inst)
Patents, Royalties, Other Intellectual Property - Circulating tumor cell novel capture technology (Inst)
Travel, Accommodations, Expenses - Astellas Scientific and Medical Affairs Inc
 
Robert Montgomery
Consulting or Advisory Role - Daiichi Sankyo/UCB Japan
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Beigene (Inst); Clovis Oncology (Inst); Janssen Oncology (Inst)
 
Elahe Mostaghel
No Relationships to Disclose
 
Jennifer Freedman
Patents, Royalties, Other Intellectual Property - pending